Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-02-05

Clinical Trial Update: TAU vs m-SBIRT in Primary Care [NA]

View source ↗

Summary

The study comparing treatment as usual (TAU) to modified SBIRT in primary care for substance use disorders has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Medical University of South Carolina | Conditions: Substance Use Disorders | NA | Status: WITHDRAWN